1. World Health Organization (WHO), Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016–2021: actions for impact: web annex 2: data methods, (2021). https://iris.who.int/handle/10665/342813 (accessed March 20, 2023).
2. Office for Health Improvement & Disparities, Liver disease profiles, March 2023 update - GOV.UK, (2023). https://www.gov.uk/government/statistics/liver-disease-profiles-march-2023-update/liver-disease-profiles-march-2023-update (accessed March 20, 2023).
3. UK Health Security Agency, Hepatitis B in England 2023: working to eliminate Hep B as a public health threat, (2023). https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1133813/Hepatitis_B_in_England_2023.pdf (accessed March 20, 2023).
4. UK Health Security Agency, Hepatitis C in the UK 2023: working to eliminate hepatitis C as a public health threat, (2023). https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1133731/hepatitis-c-in-the-UK-2023.pdf (accessed July 11, 2023).
5. Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial;Andrieux-Meyer;Lancet Gastroenterol. Hepatol.,2021